Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

Epidemiological cutoff values (ECVs) for the Cryptococcus neoformans-Cryptococcus gattii species complex versus fluconazole, itraconazole, posaconazole, and voriconazole are not available. We established ECVs for these species and agents based on wild-type (WT) MIC distributions. A total of 2,985 to...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Espinel-Ingroff, A., Aller, A. I., Canton, E., Castañón-Olivares, L. R., Chowdhary, A., Cordoba, S., Cuenca-Estrella, M., Fothergill, A., Fuller, J., Govender, N., Hagen, F., Illnait-Zaragozi, M. T., Johnson, E., Kidd, S., Lass-Flörl, C., Lockhart, S. R., Martins, M. A., Meis, J. F., Melhem, M. S. C., Ostrosky-Zeichner, L., Pelaez, T., Pfaller, M. A., Schell, W. A., St-Germain, G., Trilles, L., Turnidge, J.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2012
Sujets:
Susceptibility
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3486550/
https://ncbi.nlm.nih.gov/pubmed/22948877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01115-12
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires